Behçet Disease Clinical Trial
Official title:
Pilot Project: The Amplicon and Metatranscriptomic Next-generation Sequencing of Samples From Intra and Extra-intestinal Microbiome in Non-infectious Uveitis Patients to Decipher Possibility Uveitis Pathogenesis
This study aimed to discover the composition on the microbiome in several sites of the human body; and to find out the difference in microbiome composition on ocular fluid, blood, and feces before and after therapy in uveitis patient with history of autoimmune disease (Behcet and Vogt-Koyanagi-Harada) and idiopathic uveitis
Gut microbiome has been widely studied around the globe, and it is convinced that the gut
microbiome plays an essential role in many human diseases. In a published review showed the
presence of microbes in blood from a patient who suffered from non-communicable disease. The
microbes present in dormant or not-immediately-culturable states as if blood is a 'sterile'
environment. It was argued that the difficulty of culturing microbes from the blood was
coming from the limited understanding of suitable growth/isolation media for the microbes to
be cultured. This limitation can be overcome by the sequenced-based methods for detecting
non-proliferating microbes. The presence of microbes in blood also can be observed by
ultrastructural (microscopic) methods. Through the microscopic observations, it was
witnessing the presence of coccus and bacillus shaped bacteria that present proximity to (Red
Blood Cell) RBCs in sample blood patients with Alzheimer's or Parkinson's Disease. The
presence of microbes in the places other than their normal location state by term
'atopobiosis'. The presence of microbes in blood suspected as a result of translocation
between the gut to the blood.
Therefore, according to the current knowledge of microbiome association and the human
diseases, we are eager to conduct a pilot project that gives a comprehensive picture of the
association between the microbiome and uveitis disease partially non-infectious and
idiopathic uveitis. We will investigate microbiome profiling in the intestinal and
extra-intestinal of uveitis patients before and after treatment to see whether any alteration
of microbial abundance at two distinct clinical conditions partially in uveitis patients with
history of autoimmune disease (Behcet and Vogt-Koyanagi-Harada) and idiopathic uveitis.
Another objective of this study is to explore any pathogenic microorganism that present in
uveitis patients samples conducted by a sequenced-based method.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04528082 -
Apremilast Pediatric Study in Children With Active Oral Ulcers Associated With Behçet's Disease
|
Phase 3 | |
Recruiting |
NCT04101604 -
Biomarkers of Common Eye Diseases
|
||
Terminated |
NCT04609397 -
A Study to Evaluate the Efficacy and Safety of Hemay005 in the Treatment of Behçet Disease
|
Phase 2 | |
Not yet recruiting |
NCT05128357 -
IMPACT_BD (IMProving AdherenCe to Treatment in Behçet's Disease)
|
||
Recruiting |
NCT05879419 -
Recombinant Herpes Zoster Vaccine in Patients With Autoimmune Rheumatic Diseases
|
Phase 4 | |
Completed |
NCT03209219 -
Interferon α2a Versus Cyclosporine for Refractory Behçet's Disease Uveitis
|
Phase 3 | |
Completed |
NCT04386824 -
Erectile Dysfunction in Patients With Non Ocular Behçet's Disease
|
||
Completed |
NCT02648581 -
Efficacy and Safety of Ustekinumab, a Human Monoclonal Anti-IL-12/IL-23 Antibody, in Patients With Behçet Disease
|
Phase 2 | |
Recruiting |
NCT06451575 -
Thrombophilia and Thrombosis in Behçet's Disease
|
||
Recruiting |
NCT04530461 -
Serologic Profile of SARS CoV2 in COVID-19 Patients With Systemic Diseases
|
||
Not yet recruiting |
NCT06386744 -
Dusquetide for the Treatment of Behcet's Disease
|
Phase 2 | |
Recruiting |
NCT04334031 -
Deployment o the Multidisciplinary Prospective Cohort Imminent
|
N/A | |
Not yet recruiting |
NCT04105439 -
Plasma Soluble Urokinase Plasminogen Activator Receptor and Behçet's Disease .
|
||
Not yet recruiting |
NCT05715294 -
The Effect of Music on Sleep Quality in Behçet's Patients
|
N/A | |
Active, not recruiting |
NCT06266247 -
How Sirtuin Levels Change During Behçet Disease
|
N/A | |
Recruiting |
NCT04959435 -
Understanding the Role of Oral Microbiota in Behçet's Disease (BEHCETBIOT)
|
||
Recruiting |
NCT03837236 -
Inactivity Behavior and Exercise Bariers in Patients With Behçet Disease
|
N/A | |
Recruiting |
NCT03803462 -
Behçet's Disease Overall Damage Index
|